What are the disadvantages of liposomal?

The strongest argument against liposomal vitamin C comes from the research that supports it.

A 2025 scoping review screened 321 studies and found only 10 worth including. Across those ten, the absorption advantage ranged from 1.3-fold to 7.2-fold — a spread wide enough that the words on the label tell you almost nothing about what a given product will actually do.

Here are the real trade-offs: what "liposomal" doesn't guarantee, where the evidence stops, and who probably doesn't need it.

Table of Contents

1. What "liposomal" actually means — and what it doesn't guarantee
2. The absorption advantage is real, but the range is enormous
3. Better absorption has not been shown to mean better results
4. The label is not regulated the way you might assume
5. Cost, stability and storage
6. Who probably doesn't need liposomal vitamin C
7. What to ask before paying the premium
8. Frequently asked questions
9. The honest summary
10. Research references

1. What "Liposomal" Actually Means — And What It Doesn't Guarantee

A liposome is a microscopic vesicle built from a phospholipid bilayer enclosing a watery centre. The idea is straightforward: put vitamin C inside the centre, and it travels through the stomach shielded from acid, then crosses the gut wall by routes that bypass the saturable transporters ordinary ascorbic acid depends on. Vesicles used in published work range from 20 nanometres to over 1 micrometre in diameter.

The gap between that idea and a given bottle is where the disadvantages live. Encapsulation is never complete. In a 2021 trial that characterised its formulation with electron microscopy, encapsulation efficiency measured 65.85 ± 1.84% — meaning roughly a third of the vitamin C was not inside a liposome at all, in a product built and measured under research conditions.

So "liposomal" describes an intention, not a guaranteed quantity. A product can contain some liposomes, few liposomes, or structures that are not liposomes at all — emulsions and micelles look similar on a label and behave differently in the body. Our complete guide to liposomal vitamin C covers how the delivery system is meant to work; this page covers where it falls short.

2. The Absorption Advantage Is Real, But the Range Is Enormous

The 2025 scoping review found that 9 of the 10 included trials showed higher bioavailability for liposomal vitamin C. That is a genuine finding, and it is the reason the category exists. But the same review reported peak concentrations 1.2 to 5.4 times higher and total exposure 1.3 to 7.2 times higher, depending on the formulation, the dose and the population studied.

Consider what that range means in practice. At the top end, a product delivers seven times the exposure. At the bottom, it delivers 1.3 times — a 30% improvement. A 2024 trial of a spray-dried liposomal powder in 10 volunteers at a 1000mg dose found total exposure of 445 mg·h/L versus 342 for plain ascorbic acid, an increase of about 30%. A separate 2021 crossover trial at the same dose reported a 1.77-fold advantage.

Both results are real. They are also five-fold apart from the top of the published range. You are not buying "liposomal delivery" as a known quantity — you are buying one manufacturer's execution of it, and the published spread is the honest measure of how much that execution matters. Our guide to choosing a liposomal vitamin C supplement covers what separates the ends of that range.

3. Better Absorption Has Not Been Shown to Mean Better Results

This is the most important limitation, and it is the one most rarely mentioned. Higher blood levels are a measurement, not an outcome. The question that matters is whether those higher levels change anything you would notice, and on that the evidence is thin.

The clearest test came in 2016. Eleven adults received a 4g dose of vitamin C on four separate occasions — as placebo, plain oral, oral liposomal, or intravenously — and then underwent a forearm ischemia-reperfusion procedure designed to provoke oxidative stress. Liposomal delivery did raise blood levels, producing total exposure of 10.3 versus 7.6 mg/dL·h for plain oral. That trial was funded by a liposomal supplement manufacturer, and one of its authors owns a company that sells liposomal vitamin C — which makes the next finding more striking, not less. At the functional endpoint, every vitamin C treatment prevented the rise in oxidative stress markers equally. Plain oral matched liposomal. Plain oral also matched intravenous.

A 2024 trial in 27 adults points the same way from a different angle. Liposomal delivery raised plasma exposure by 21% and plasma peak by 27%, but exposure inside white blood cells rose by just 8% — the smallest gain in the study, in precisely the cells that concentrate vitamin C for immune function. The absorption advantage is established. The clinical outcome advantage is not, and anyone telling you otherwise is ahead of the data.

4. The Label Is Not Regulated the Way You Might Assume

In November 2021, the UK Advertising Standards Authority ruled that a marketed liposomal vitamin C product's liposomal claims were unsubstantiated and therefore misleading, breaching CAP Code rules 3.1 and 3.7. The regulator had the brand's evidence reviewed by the Laboratory of the Government Chemist, which noted the sample had been diluted 1:400,000 in water before testing — a dilution capable of destroying any liposomes present — with no quality control evidence ruling that out.

The contrast with pharmaceuticals is instructive. The FDA's 2018 guidance on liposome drug products sets out what manufacturers are expected to document before a liposomal medicine reaches market — particle size, lamellarity, encapsulation efficiency, in-vitro release and process controls. None of that applies to a supplement that prints the word on its label.

The practical consequence: verification has to come from the manufacturer voluntarily, not from a regulator. Independent batch testing and a certificate of analysis are the only things standing between a claim and a measurement, which is why they are worth more than any absorption figure printed on a box.

5. Cost, Stability and Storage

Liposomal formulations cost more than plain ascorbic acid, and the reason is legitimate: producing and characterising stable vesicles is a demanding manufacturing process. The difficulty is knowing what you get for the premium. Given a published range running from 1.3-fold to 7.2-fold, a buyer paying more has no way to know from the label whether they are buying the top of that range or the bottom.

Stability is the second practical trade-off. Liposomes are thermodynamically unstable multiphase systems, and vesicle fusion, aggregation and oxidative degradation of the lipids are recognised problems in pharmaceutical development. Vitamin C is itself unstable in water, degrading faster at high pH and in the presence of oxygen and metal ions. A liquid liposomal product is therefore two unstable systems in one bottle.

That shapes how you store it. Liquid formats generally need refrigeration after opening and are less forgiving of heat and time than a dry powder or capsule. Capsule and powder formats sidestep most of this — the 2024 spray-dried powder trial found the drying process did not adversely affect carrier particle quality — which is a reasonable argument for choosing a solid format if your storage conditions are unpredictable.

6. Who Probably Doesn't Need Liposomal Vitamin C

The saturation problem that liposomal delivery solves is real, but it only appears at doses most people never take. Vitamin C absorption sits at 70–90% at intakes of 30–180mg a day, and only falls below 50% above 1g a day. The RDA is 90mg for men and 75mg for women.

If you are taking 200mg to meet the RDA with margin, you are operating in the range where ordinary vitamin C is absorbed efficiently and the delivery system has little left to improve. The people with a real case are those targeting the higher intakes where the transporters saturate, those who find high-dose ascorbic acid hard on the stomach, and those with elevated requirements — smokers, for instance, need an extra 35mg a day.

The evidence base itself is a reason for restraint. A systematic search of Embase and Medline in October 2024 returned 13 studies across all enhanced vitamin C forms, of which only 3 reported bioavailability data for liposomal encapsulation. Individual trials have been small: 27 adults in one, 11 in another, 10 in a third. That is an early evidence base, not a settled one. For the general safety picture at higher intakes, see our article on vitamin C side effects and the upper limit.

7. What to Ask Before Paying the Premium

If the disadvantages above come down to one thing, it is verification. The category's weakness is that "liposomal" is a claim anyone can print, so the only useful question is what a manufacturer can show you.

Three things are worth asking. First, is every batch tested by an independent laboratory, and is the certificate of analysis available on request? Second, is the phospholipid source named on the label rather than hidden behind the word "liposomal"? Third, does the allergen profile hold up — particularly the ascorbic acid source, which is corn-derived in most of the market and matters if you react to corn.

It seems only fair to answer our own three questions. Bio Absorb Nutraceuticals' Liposomal Vitamin C is made in Canada, in a GMP-certified, Health Canada-approved facility. Every batch is tested by an independent laboratory, and the certificate of analysis is available on request.

On the second, the full ingredient panel — phospholipid source included — is shown on each product page, so it can be read rather than requested. On the third, the formulation is verified corn-free rather than assumed corn-free, alongside non-GMO, gluten-free, nut-free, dairy-free, vegan and non-irradiated. That last group matters more than it looks: corn is not a labelled allergen, and most ascorbic acid begins life as corn — the subject of our guide to why the source of ascorbic acid matters.

There are two formats. Liposomal Vitamin C Liquid 1000mg (Corn-Free) carries a natural orange flavour and mixes with water or juice. Liposomal Vitamin C Capsules 1000mg (Corn-Free) are tasteless, need no refrigeration and travel without fuss. The choice is one of routine rather than chemistry, and both carry a 100% money-back guarantee.

None of that makes the category's limitations disappear; they apply to everyone selling liposomal vitamin C, ourselves included. We would rather you read this page and decide you do not need it than buy it on a claim nobody has verified. If you decide the higher intakes apply to you, see the full product specification and current serving details for the liquid, or current pricing and serving details for the capsules.

Frequently Asked Questions

Is liposomal vitamin C worth the extra cost?

It depends entirely on your intake and on the specific product. At intakes of 30–180mg a day, ordinary vitamin C is already 70–90% absorbed, so there is little room to improve. The case strengthens at higher doses where absorption falls below 50%, but even then the published advantage ranges from 1.3-fold to 7.2-fold depending on the formulation.

Does liposomal vitamin C have more side effects than regular vitamin C?

Generally the opposite — liposomal delivery is often better tolerated at higher doses because less unabsorbed ascorbic acid reaches the lower gut. The 2000mg/day tolerable upper intake level still applies regardless of format. Our article on vitamin C side effects and the upper limit covers this in detail.

How can I tell if a liposomal supplement actually contains liposomes?

You cannot tell from the label, which is the core problem — the 2021 ruling by the UK advertising regulator turned on exactly this question. Ask the manufacturer for third-party characterisation data or a certificate of analysis. A brand that can produce one is telling you something a claim cannot.

Does liposomal vitamin C need to be refrigerated?

Liquid formats usually do after opening, because liposomes degrade with heat and time and vesicle fusion and lipid oxidation are known stability problems. Capsules and powders are generally more stable and need no refrigeration. Follow the storage instructions on the specific product.

Is liposomal vitamin C as good as an IV drip?

Not for blood levels. In the 2016 four-arm trial, intravenous delivery produced significantly higher plasma concentrations than every oral treatment at every time point. What is interesting is that at the oxidative stress endpoint, all three vitamin C treatments performed the same.

Can you take too much liposomal vitamin C?

Yes. The 2000mg/day upper limit applies to total intake from all sources, and better absorption means a given dose delivers more. Anyone with kidney disease, a history of kidney stones, or haemochromatosis should speak to their doctor before supplementing at any dose, in any format.

The Honest Summary

Liposomal vitamin C has a real absorption advantage, and a published range of 1.3-fold to 7.2-fold that makes the specific product matter far more than the category. What it does not yet have is evidence that higher blood levels produce better outcomes. If you are taking modest doses, plain ascorbic acid is likely enough; if the higher intakes apply to you, choose on verification rather than on the word "liposomal", and check the full product specification before you buy.

Research References

1. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1, article e70067 (2025). Screened 321 studies and included 10; found peak concentrations 1.2–5.4 times higher and total exposure 1.3–7.2 times higher for liposomal versus non-liposomal vitamin C — the source of the variability argument running through this article.
2. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition, Vol. 63, Issue 8, pp. 3037–3046 (2024). In 27 adults at a 500mg dose, liposomal delivery raised plasma exposure 21% and plasma peak 27%, but leukocyte exposure only 8%.
3. Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia–Reperfusion Injury. Nutrition and Metabolic Insights, Vol. 9, pp. 25–30 (2016). Four-arm trial in 11 adults; liposomal delivery raised blood levels above plain oral, but all vitamin C treatments blunted oxidative stress equally — the basis for this article's central limitation. Funded by a liposomal supplement manufacturer; one author owns a company selling liposomal vitamin C.
4. Evaluation and clinical comparison studies on liposomal and non-liposomal ascorbic acid (vitamin C) and their enhanced bioavailability. Journal of Liposome Research, Vol. 31, Issue 4, pp. 356–364 (2021). Reported a 1.77-fold bioavailability advantage at 1000mg and an encapsulation efficiency of 65.85 ± 1.84%.
5. Bioavailability of Liposomal Vitamin C in Powder Form: A Randomized, Double-Blind, Cross-Over Trial. Applied Sciences, Vol. 14, Issue 17, article 7718 (2024). In 10 volunteers at 1000mg, total exposure was 445 mg·h/L versus 342 for non-liposomal, and spray drying did not degrade carrier particle quality.
6. Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults. Nutrients, Vol. 17, Issue 2, article 279 (2025). An October 2024 systematic search returned 13 studies across all enhanced vitamin C forms, of which only 3 reported liposomal bioavailability data.
7. Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update. International Journal of Pharmaceutics, Vol. 624, article 122022 (2022). Describes vesicle fusion, aggregation and oxidative lipid degradation as recognised stability problems in liposomal products.
8. ASA Ruling on YourZooki Ltd (ref A20-1083951). Advertising Standards Authority, United Kingdom (2021). Ruled that liposomal claims for a marketed vitamin C product were unsubstantiated and misleading, breaching CAP Code rules 3.1 and 3.7.
9. Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation. US Food and Drug Administration, Center for Drug Evaluation and Research (2018). Sets out the characterisation required of liposomal medicines, none of which applies to dietary supplements.
10. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health — Office of Dietary Supplements. Source for absorption of 70–90% at intakes of 30–180mg/day, the fall below 50% above 1g/day, the RDA, the additional 35mg/day for smokers, and the 2000mg/day tolerable upper intake level.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.